Markulan, L., and L. Makarevych. “Pembrolizumab As an Immunotherapy Drug in the Treatment of a patient with recurrent (unresectable) Cancer of the Lower Lip”. General Surgery, no. 2, Dec. 2022, pp. 75-82, doi:10.30978/GS-2022-2-75.